Clinical trials
Lung clinical trials
Below are recruiting lung clinical trials, each written for real people, not researchers. We’re tracking 2,885 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06535451Recruiting
Lung cancer screening for people at high risk
This study offers free lung cancer screening (a CT scan) to people aged 50 and older who are at higher risk due to smoking, wood smoke exposure, or COPD. It aims to catch cancer early, when it's easier to treat.
Mexico City, TlalpanAges 50 years+ - NCT06537934Recruiting
Advanced CT scan to check heart and lung health in lung disease
This study uses a special high-resolution CT scan to look at heart and lung problems in people with a type of lung disease that gets worse over time. It may help doctors understand how the heart is affected and guide better care.
MilanAges 18 years+ - NCT06538636Recruiting
Improving lung cancer screening for Veterans
This study is testing a new way to find Veterans who might benefit from yearly lung cancer screening. It uses a computer model to estimate your personal benefit, even if you don't fit the usual screening guidelines.
Bedford, MassachusettsAges 50–80 - NCT06540495Recruiting
Virtual exercise program for lung cancer patients
This trial tests a personalized exercise program you can do from home using a computer or tablet. It’s for people with non-small cell lung cancer at different stages of treatment, and aims to help improve strength and well-being.
New Hyde Park, New YorkAges 18 years+ - NCT06546007Recruiting
Blood and tissue markers to detect lung cancer early
This study is testing whether certain markers in your blood or tissue can help find lung cancer early. It is for people who have lung cancer that can be removed by surgery and haven't had treatment yet.
RomaAges 35–85 - NCT06548386Recruiting
A new device to check for air leaks after lung surgery
This study is testing a new tool that checks for air leaks in the chest tube placed after lung surgery. An air leak can slow down recovery, and this device may help doctors detect it more accurately.
Evanston, IllinoisAges 18 years+ - NCT06548711Recruiting
Acupoint stimulation for cough after lung cancer surgery
This trial tests if a gentle electrical stimulation on your skin at specific points (acupoints) can help reduce a dry cough that lasts 2 weeks or more after lung cancer surgery.
Tianjin, Tianjin MunicipalityAges 18–80 - NCT06559059Recruiting
Virtual cancer program for Veterans with new cancer
This study looks at how well a virtual (telemedicine) cancer program works for Veterans who are newly diagnosed with lung, prostate, breast, or colon cancer. Participation involves a telemedicine visit at a VA medical center instead of traveling to the hospital.
Brooklyn, New YorkAges 18 years+ - NCT06561386RecruitingPhase 3
Testing a new drug combo for advanced lung cancer
This trial is comparing a new combination of two immunotherapy drugs (nivolumab and relatlimab) plus chemotherapy against the standard immunotherapy (pembrolizumab) plus chemotherapy for people with advanced non-squamous non-small cell lung cancer that has a certain protein (PD-L1) on at least 1% of its cells. The goal is to see if the new combination works better.
Mobile, AlabamaAges 18 years+ - NCT06562920RecruitingPhase 2
Immunotherapy plus chemo and SBRT before surgery for limited-stage small cell lung cancer
This trial tests a combination of immunotherapy (adebrelimab), chemotherapy, and targeted radiation (SBRT) before surgery for people with limited-stage small cell lung cancer. The goal is to see if this approach can shrink tumors and improve outcomes before the main treatment.
Hangzhou, ZhejiangAges 18–75 - NCT06564324RecruitingPhase 3
Comparing taletrectinib to standard therapy for ROS1-positive lung cancer
This study compares a new targeted therapy pill (taletrectinib) to standard treatments for people with advanced ROS1-positive lung cancer. The goal is to see if taletrectinib works better at shrinking tumors and delaying cancer growth.
Hefei, AnhuiAges 18 years+ - NCT06566443RecruitingPhase 1
Honokiol for early-stage lung cancer before surgery
This trial tests a natural compound called honokiol in people with early-stage non-small cell lung cancer who are scheduled for surgery. The goal is to see if honokiol can help shrink or control the tumor before it is removed.
Houston, TexasAges 18 years+ - NCT06572384RecruitingPhase 3
Belimumab for lung scarring in autoimmune disease
This study tests whether a drug called belimumab can help people with lung scarring caused by certain autoimmune diseases (like rheumatoid arthritis or lupus). If you have active lung disease despite standard therapy, this trial may be an option.
Los Angeles, CaliforniaAges 18 years+ - NCT06572540Recruiting
Cryoablation for early-stage lung cancer
This trial compares two ways to freeze and destroy small lung tumors: through the chest wall or through the airways. It’s for people with early-stage lung cancer who are not able or willing to have surgery.
Guangzhou, GuangdongAges 18 years+ - NCT06575439Recruiting
Study of lung cancer in people who have never smoked
This study looks at why some people who have never smoked develop lung cancer. Researchers will follow participants to learn about predictors and outcomes, with the goal of improving care for non-smokers with lung cancer.
LondonAges 18 years+ - NCT06577844Recruiting
Video support for lung cancer surgery patients
This trial tests whether a video tool helps patients prepare for lung cancer surgery. It aims to improve understanding and reduce anxiety before and after the procedure.
MarseilleAges 18 years+ - NCT06577883Recruiting
New chest X-ray technique for lung cancer screening
This trial tests a new type of chest X-ray called tomosynthesis to improve lung cancer screening. It looks at people who are getting screened for lung cancer, have a suspicious spot on their lung, or have just been diagnosed—as long as they haven't been treated for lung cancer before.
San Diego, CaliforniaAges 30–85 - NCT06582940RecruitingPhase 2
MRI-guided radiation for lung cancer with brain metastases
This trial tests a new way to deliver radiation to brain metastases from non-small cell lung cancer, using MRI scans to guide the treatment and reduce the area exposed. The goal is to see if this approach is safe and effective while possibly lowering side effects.
Guangzhou, GuangdongAges 18–75 - NCT06586957RecruitingPhase 1
Study of NKT3964 for advanced solid tumors
This trial is testing an experimental oral drug called NKT3964 for people with advanced solid tumors that have stopped responding to standard treatments. The drug works by blocking a protein called CDK2, which some cancers need to grow.
Little Rock, ArkansasAges 18 years+ - NCT06589778RecruitingPhase 1/Phase 2
Study of three drugs for advanced lung cancer
This trial tests a combination of three drugs (SHR-A2102, Adebrelimab, and SHR-8068) for people with advanced non-small cell lung cancer that cannot be removed by surgery. It aims to see if this combination can shrink or slow the growth of the cancer.
Shanghai, Shanghai MunicipalityAges 18–70 - NCT06592638RecruitingPhase 1
ZG006 for small cell lung cancer
This trial tests a new drug called ZG006 for people with small cell lung cancer that has not responded to or can no longer tolerate standard treatments. The goal is to find the best dose and see if it can help shrink or control the cancer.
Orange, CaliforniaAges 18–75 - NCT06594601Recruiting
Adjusting ventilator pressure for ARDS patients using 3D EIT
This study uses a special chest monitor to find the best ventilator pressure setting for people with ARDS on breathing machines. It aims to improve treatment by tailoring the pressure to each patient's lungs.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06598527RecruitingPhase 3
Radiation and immunotherapy before surgery for lung cancer
This trial tests adding targeted radiation before standard immunotherapy and chemotherapy for people with stage 2-3 non-small cell lung cancer that can be surgically removed. The goal is to see if the radiation helps shrink the tumor more before surgery.
Guangzhou, GuangdongAges 18–75 - NCT06598306RecruitingPhase 1
Tarlatamab injection for advanced small cell lung cancer
This trial tests a new drug called tarlatamab, given as an injection under the skin (like a shot), for people with advanced small cell lung cancer that has worsened after chemotherapy. The goal is to see if this treatment can help shrink or slow down the cancer.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Lung trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lung?
- Yes. Clin2 currently lists 2,885 recruiting lung studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lung trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lung trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.